NAVANE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Navane, and what generic alternatives are available?
Navane is a drug marketed by Pfizer and is included in three NDAs.
The generic ingredient in NAVANE is thiothixene hydrochloride. There are six drug master file entries for this compound. Additional details are available on the thiothixene hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NAVANE?
- What are the global sales for NAVANE?
- What is Average Wholesale Price for NAVANE?
Summary for NAVANE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Patent Applications: | 6,301 |
| DailyMed Link: | NAVANE at DailyMed |
US Patents and Regulatory Information for NAVANE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | NAVANE | thiothixene | CAPSULE;ORAL | 016584-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | NAVANE | thiothixene hydrochloride | INJECTABLE;INJECTION | 016904-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | NAVANE | thiothixene | CAPSULE;ORAL | 016584-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | NAVANE | thiothixene hydrochloride | INJECTABLE;INJECTION | 016904-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
